Rare Diseases
News from NORD
Film Festival Devoted to Rare Diseases Scheduled for October
News from NORD
Save the Date for the 2017 NORD Summit
News from NORD
NORD and Neurology Reviews Publish Special Report
News from NORD
NORD Announces Recipients of 2017 Rare Impact Awards
FDA/CDC
FDA approves first home genetic health risk test
Consumers do seem to want to know.
FDA/CDC
FDA approves deutetrabenazine for Huntington’s-associated chorea
Deutetrabenazine is only the second product approved to treat Huntington’s in any capacity, and it is the first in nearly a decade.
Conference Coverage
Anthony Fauci faces the ‘perpetual challenge’ of emerging infections
SAN DIEGO – NIAID Director Anthony S. Fauci, MD, can say one thing for certain: Emerging and re-emerging infectious diseases in the United States...
News from NORD
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
News from NORD
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
Literature Review
Pitolisant Reduces Cataplexy Attacks in Narcolepsy
Pitolisant, a histamine H3 receptor inverse agonist, is well tolerated and effectively reduces cataplexy, according to data published in the March...